Dong Xu

机构：World Health Organization - Pakistan · ORCID：0000-0002-6413-3043

发表论文 212 篇 · 总被引 4467 次 · h-index 35

代表论文

• Fourteen-day vonoprazan-amoxicillin dual therapy versus 14-day bismuth-based quadruple therapy for Helicobacter pylori treatment: a randomized clinical trial (2025 · Therapeutic Advances in Gastroenterology · 被引 9)
• Is high IgG level associated with disease activity and organ damage in patients with Sjögren’s syndrome? A 3-year follow-up cohort study (2025 · Clinical and Experimental Medicine · 被引 6)
• Bibliometric insights into systemic sclerosis with renal involvement: trends, contributions, and future directions (2025 · Renal Failure · 被引 3)
• Limitations and risks of custom GPTs in dermatology. Comment on “ReconGPT: A novel artificial intelligence tool and its potential use in post-Mohs reconstructive decision-making” (2025 · Journal of the American Academy of Dermatology · 被引 3)
• A causal relationship between type 1 diabetes and risk of systemic sclerosis: a bidirectional two-sample Mendelian randomization study (2025 · Diabetology & Metabolic Syndrome · 被引 2)
• Correspondence on ‘Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score’ by Pecher et al (2026 · Annals of the Rheumatic Diseases · 被引 1)